Minocycline Use in Moderate‑to‑Severe Inflammatory Acne

Dosing Recommendations

Standard adult dosing: 50 mg taken once daily up to three times daily for moderate‑to‑severe inflammatory acne in patients ≥8 years, always combined with topical benzoyl peroxide and/or a retinoid. (American Academy of Dermatology) 1
Pediatric dosing (≥8 years): Initiate with 4 mg/kg, then continue with 2 mg/kg every 12 hours; same combination therapy requirement applies. (American Academy of Dermatology) 3

Limit systemic antibiotic courses: Re‑evaluate after 3–4 months to minimize bacterial resistance; discontinue when clinical improvement is achieved. (American Academy of Dermatology) 6
Post‑antibiotic maintenance: Continue topical benzoyl peroxide and/or retinoid after stopping systemic minocycline to sustain results. (American Academy of Dermatology) 4

Pregnancy (Category D): Contraindicated because of risk of embryopathy and permanent tooth discoloration. (American Academy of Dermatology) 4
Children younger than 8 years: Contraindicated unless benefits clearly outweigh risks due to risk of permanent tooth discoloration and enamel hypoplasia. (American Academy of Dermatology) 3
Breastfeeding: Contraindicated; drug is secreted in milk and should be stopped or nursing discontinued. (American Academy of Dermatology) 3

Avoid monotherapy: Minocycline must be used together with a topical benzoyl peroxide and/or retinoid to prevent bacterial resistance, provide synergistic therapeutic effects, and allow safe maintenance after antibiotic discontinuation. (American Academy of Dermatology) 6

Serious adverse event rate: 8.8 cases per 100,000 patient‑years, higher than other tetracyclines. (American Academy of Dermatology) 8
Common gastrointestinal side effects: Nausea, vomiting, diarrhea, dyspepsia. (American Academy of Dermatology) 3
Pigmentation risk: Skin, mucous membranes, teeth, and nails may develop blue‑gray discoloration, especially with cumulative doses >70 g. (American Academy of Dermatology) 7
Vaginal candidiasis: Reported as a frequent side effect. (American Academy of Dermatology) 8
Rare but severe reactions:
- Hepatotoxicity (cholestasis, fatal hepatic failure, autoimmune hepatitis). (American Academy of Dermatology) 3
- Hematologic toxicity (agranulocytosis, hemolytic anemia, thrombocytopenia). (American Academy of Dermatology) 3
- Cardiovascular toxicity (myocarditis, pericarditis). (American Academy of Dermatology) 4
- Respiratory toxicity (pneumonitis, bronchospasm). (American Academy of Dermatology) 4
Comparative safety:
- Less photosensitizing than doxycycline. (American Academy of Dermatology) 8
- Doxycycline causes more gastrointestinal side effects than minocycline. (American Academy of Dermatology) 8

Antacids (Al‑, Ca‑, Mg‑containing): Decrease minocycline absorption; separate by 2–3 hours. (American Academy of Dermatology) 3
Oral anticoagulants: May potentiate anticoagulant effect; monitor coagulation parameters. (American Academy of Dermatology) 2
Hormonal contraceptives: May reduce efficacy; advise backup contraception. (American Academy of Dermatology) 7
Isotretinoin: Increases risk of pseudotumor cerebri; avoid concurrent use. (American Academy of Dermatology) 4
Methoxyflurane: Heightens nephrotoxicity risk; avoid co‑administration. (American Academy of Dermatology) 1
Penicillins: May interfere with bactericidal activity of minocycline. (American Academy of Dermatology) 7

Combination therapy: Emphasize that minocycline must never be used alone; always pair with topical benzoyl peroxide and/or a retinoid. (American Academy of Dermatology) 6
Pregnancy prevention: Advise reliable contraception; minocycline is contraindicated in pregnancy. (American Academy of Dermatology) 1
Treatment length: Expect therapy for 3–4 months; not intended for indefinite use. (American Academy of Dermatology) 6
Vestibular symptoms: Promptly report dizziness, vertigo, or tinnitus. (American Academy of Dermatology) 7
Pigmentation warning: Inform about possible blue‑gray discoloration of skin or teeth with prolonged therapy. (American Academy of Dermatology) 7
Photosensitivity: Use sun protection; risk is lower than with doxycycline. (American Academy of Dermatology) 8
Severe headache: Seek immediate care as it may signal pseudotumor cerebri. (American Academy of Dermatology) 8
Autoimmune symptoms: Report fever, rash, joint pain, or systemic signs promptly. (American Academy of Dermatology) 8
Administration tips: Take with adequate fluid; separate from antacids, iron, and dairy products by 2–3 hours. (American Academy of Dermatology) 1

First‑line therapy: Tetracycline class agents (including minocycline) are recommended as first‑line for moderate‑to‑severe inflammatory acne, unless contraindicated. (American Academy of Dermatology) 8
Alternative antibiotics for pregnancy or children <8 years: Erythromycin or azithromycin may be used, recognizing higher resistance rates. (American Academy of Dermatology) 7